---
title: Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
date: '2025-01-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39879593/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20250130170934&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Consistent results across all the analyses support the
  noninferior efficacy of three all-oral shortened regimens for the treatment of rifampin-resistant
  tuberculosis. (Funded by Unitaid and others; endTB ClinicalTrials.gov number, ...'
disable_comments: true
---
CONCLUSIONS: Consistent results across all the analyses support the noninferior efficacy of three all-oral shortened regimens for the treatment of rifampin-resistant tuberculosis. (Funded by Unitaid and others; endTB ClinicalTrials.gov number, ...